© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Benorilate came around in the middle of the twentieth century, during a time when researchers kept searching for ways to ease pain and lower fever without the well-known side effects that common medicines often brought. Back then, many doctors had their hands tied by the harshness of aspirin or the unpredictable problems of paracetamol on its own, especially when working with children. Benorilate, a compound joining aspirin and paracetamol, caught scientists’ attention as early as the 1960s. They hoped that mixing the two would keep the pain-fighting power strong while cutting down on the harsh blows to the stomach and liver. Though newer drugs have entered the spotlight, the unique history of benorilate offers important lessons about combining old remedies to open up new possibilities.
Benorilate pulls together the key strengths of two classic drugs: paracetamol (acetaminophen) and aspirin (acetylsalicylic acid). It stands out as a covalent ester of both, aiming to tackle fever, headache, or pain from inflammation. On the shelf, the powdered or granular formulations come with straightforward instructions, and each batch typically contains a set ratio of both active ingredients. In medical circles, benorilate mostly went to work for children struggling with viral infections, though the market has shifted over the years as younger patients respond better to other modern anti-inflammatories. Still, the blending concept has helped shape how combination drugs get designed today.
Benorilate sits in the world of white, odorless, crystalline powders. Its melting point usually pops up around 100°C, and its solubility in water remains low. Chemists often note the stearic stability and decent shelf-life under dry storage, though the compound doesn’t handle damp air very well. With its molecular formula of C17H15NO5 and a molecular weight just over 313 g/mol, it’s a molecule of moderate size for a drug of its class. The compound avoids quick breakdown, but the body’s enzyme systems can steadily cleave benorilate into paracetamol and aspirin within hours of ingestion, feeding into its medical role.
Most benorilate products come marked for oral use, in tablet or granular form. Standard tablets run from 250 mg to 500 mg of active ingredient, each wrapped in child-resistant blister packs. Product inserts explain the composition in detail: 1:1 molar ratios of aspirin and paracetamol, bound by an ester linkage. Recommended temperature and moisture limits appear on every package, reminding users to keep benorilate in cool, low-humidity places to prevent premature breakdown. Labels pull no punches about who should avoid the drug—patients with bleeding disorders, asthma, or a past allergy to aspirin steer clear. Guidelines also call out the risks of Reye’s syndrome, making it clear that benorilate should never mix into a regimen for children recovering from viral illnesses like chickenpox or influenza.
Chemists prepare benorilate by merging paracetamol and acetylsalicylic acid through an esterification step, often using agents like dicyclohexylcarbodiimide (DCC) in the presence of a catalyst. The reaction typically runs in an anhydrous organic solvent, such as chloroform or dichloromethane, under a blanket of inert gas. Purification often means washing out unreacted starting materials and using recrystallization to get pure benorilate, free of side products. The final yield can depend on precise temperature control and handling of moisture through each stage.
Benorilate holds its structure stable in standard storage conditions, but it breaks down through hydrolysis in the acidic environment of the stomach or under enzymatic action in the liver. As soon as the ester link splits, patients end up with a dose of paracetamol and aspirin. Researchers have tried to modify benorilate to improve release rates or reduce side effects, sometimes adding substituents to tweak how quickly it splits or how easily it reaches its target tissue. Few of these offshoots have seen the same level of study as the parent compound, but the research speaks to ongoing efforts to balance benefit and risk.
People might stumble onto benorilate under other names in the world literature. In pharmacy textbooks, it pops up as N-(4-hydroxyphenyl)acetylsalicylamide, or just as its international nonproprietary name (INN), benorilate. On commercial lines, certain European suppliers sold it under brand names like "Benoral," "Benolid," or "Benorylate." In some markets, a doctor might have seen it listed as a “paracetamol-aspirin ester.” If a researcher combs global regulatory directories, the USAN (United States Adopted Name) sticks with benorilate, aligning with the INN.
Every bottle or blister of benorilate lands on shelves with a laundry list of safety warnings. Allergic reactions unfold rarely, but the consequences can be severe; anaphylaxis, bronchospasm, or skin reactions have all landed in medical journals. Those warnings matter even more for people who live with asthma or a tight history of aspirin allergy. Because the body cleaves benorilate into aspirin, the same risks of gastrointestinal bleeding or peptic ulcer surface with regular use. Paracetamol’s part of the molecule drags its own baggage—liver damage at high dose or with alcohol, risks heightened in patients with liver disease or chronic alcohol use. The labeling also cautions health professionals about overdosing; the compound’s split into its components means poisoning can follow either path, needing urgent attention in emergency rooms.
Doctors mostly turned to benorilate for children with fevers or painful inflammatory illness, hoping to sidestep the worst of aspirin’s side effects while offering better relief than paracetamol solo. In some regions, combined anti-inflammatory and fever-lowering effects found favor for conditions like juvenile arthritis or in cases of persistent headache resistant to single agents. Its use fell out of favor when links between aspirin-type drugs and Reye’s syndrome became better known. Today, its use remains highly limited, with other combination painkillers or non-steroidal anti-inflammatory drugs taking precedence. Still, some specialists in pediatric rheumatology or pain management have kept an eye on formulations that echo benorilate’s twin approach, seeking new ways to help patients who don’t tolerate standard regimens.
Across the decades, benorilate has gathered attention in both laboratory and clinical settings. Research teams mapped its pharmacokinetics, showing how the compound breaks down and spreads in blood and tissue. Clinical data cataloged its pain-relieving and fever-lowering power, mostly matching what could be achieved by using both aspirin and paracetamol together. Academic interest hasn’t disappeared; recent studies in medicinal chemistry circles look for new esters along these lines, hoping to increase potency or cut down on side effects. Still, head-to-head trials against other modern anti-fever drugs usually tip the balance away from benorilate, especially where aspirin’s risks for children come into play.
Benorilate faces the same scrutiny all dual-action medicines get. Toxicity studies flagged the expected risks: bleeding in the stomach, liver injury, or allergic reaction, in line with both parent drugs. Animal testing over the years measured doses required for serious harm, confirming that overdose tracks closely with toxicity profiles seen for both aspirin and paracetamol. Chronic dosing in experimental models also flagged subtle risks, such as kidney stress or subtle inflammation in the gut, which matter most to users with underlying health problems. After multiple cases of Reye’s syndrome came to light in pediatric patients who took aspirin-containing drugs, regulators dialed back use of benorilate in nearly every country, reinforcing advice to keep it out of all regimens for children with viral illnesses.
Interest in benorilate runs cooler than in earlier years, but its story isn’t finished. Drug designers still look to combination molecules as a template for fresh options: blending old, well-known medicines in new ways can create tools with the punch of two classics while dropping some of their drawbacks. Researchers also keep searching for ways to safely deliver ester-linked drugs with built-in controls on how and where those links break—hoping to limit side effects and boost safety. Though benorilate itself may not return to pharmacy shelves for most patients, the thinking behind it fuels active work in pain and fever management. Its legacy carries forward, whether in the lab or in the thinking that guides the next round of painkiller innovation.
Benorilate often finds its way into the medicine cabinets of families dealing with pain and fever in children. This compound belongs to a group of medicines you might recognize—combining ingredients related to both aspirin and paracetamol. Parents tend to trust this sort of blend, especially if their own childhoods included a spoonful of syrup for the aches and temperatures that circle every winter. In places where it’s still prescribed, doctors turn to benorilate for its ability to tone down both pain and the heat of a fever.
Doctors tend to look for medicines that work gently but get the job done. Years ago, the thinking was that mixing the benefits of aspirin and paracetamol would let families enjoy the fever-reducing power of one and the pain relief from the other. Benorilate tries to walk that middle ground. Aspirin has strong anti-inflammatory effects, but it brings risks—especially for young children—so blending it with a milder drug was seen as progress.
Paracetamol usually gets praise for lowering fevers without upsetting stomachs. But add in aspirin’s strengths, and you get something meant to soothe joint pains, toothaches, headaches, or the stubborn fevers of flu. This made benorilate a logical pick for children’s treatments, at least in theory.
As years pass, the story changes. Medical research keeps peeling back new facts. The world found out about the link between aspirin and Reye’s syndrome—a rare but dangerous illness that can strike children after a viral infection. Suddenly, the mood shifted. Some countries began phasing out medicines with aspirin derivatives for anyone under sixteen. Benorilate didn’t escape that net. European and American health authorities started to warn parents and prescribers.
I recall in my own family, the transition away from these blended medicines caused confusion. My own mother clung to the familiar names because “they always worked.” It took one trusted pediatrician and a clear explanation on the risks before she stopped reaching for that bottle every cold season. The learning process can be slow—especially when personal experience tells you something helped in the past.
Today, doctors rarely write out a prescription for benorilate. The evidence nudged people toward safer and simpler medicines for children’s fevers and pains. In most homes now, you’ll find pure paracetamol or ibuprofen. Both offer a track record that lines up better with what science knows about kid safety. Parents and grandparents sometimes push back, not out of ignorance, but from loyalty to what comforted their families before. Still, the facts don’t lie. Avoiding unnecessary risks means less stress for everyone later.
Speak with pharmacists or healthcare professionals before giving a child any medicine—especially if the drug isn’t familiar or comes from old advice. Old remedies aren’t always the safest, even if past generations used them without issue. I’ve seen the benefits of asking questions and reviewing new guidelines. Trust forms slowly, but the goal remains the same: less pain, less fever, more safety.
Benorilate combines aspirin and paracetamol. Doctors used to suggest it for children dealing with fevers and pain. Over time, people noticed this drug comes with some issues, especially for kids. I remember looking after my nephew with a high fever, and the doctor said to avoid certain medications–Benorilate was one of them.
A medicine works in the body, but it also brings risks. With Benorilate, these risks can bother more than they help. Common reactions involve the stomach. Nausea creeps in, or a stomach ache can spoil an afternoon. Vomiting or a sour stomach made it tough for my cousin, who used this medication years ago. Later, he switched to plain paracetamol, and his stomach issues calmed down. The risk for younger folks, especially kids, can climb even higher. After reports of Reye's syndrome surfaced, safety concerns grew. Reye’s syndrome is rare but serious, causing damage to the liver and brain. It pushes families and doctors to look elsewhere for relief.
Benorilate contains components that thin blood and tax the liver. Aspirin can sometimes lead to bleeding in the stomach, especially at higher doses or in people who already have problems with ulcers. For folks with asthma, it may tighten breathing tubes, causing coughing or wheezing. Skin rash or allergic reactions show up from time to time. In rare cases, serious allergic responses mean swelling of the face or throat. Sitting in an emergency room for allergy testing with my neighbor brought the message home–even drugs that seem routine deserve respect.
Giving Benorilate to children raises special worries. In the 1980s, doctors saw a link between aspirin-type drugs and Reye’s syndrome. Children struggling to recover from viruses like flu or chickenpox sometimes faced liver trouble. Medical guides around the world started recommending different approaches for young patients. Working with healthcare in my own family showed me that parents trust advice more when they hear stories of true risk. There’s a reason most pediatricians now recommend acetaminophen or ibuprofen instead.
Knowing the downsides, it helps to talk straightforwardly with doctors or pharmacists. Ask questions about which medicine fits a situation. Children under 16 should avoid Benorilate unless a doctor says otherwise. Adults with a history of ulcers, asthma, or allergy should double-check before taking it. Check packaging for updated safety info. I stick to simple remedies unless the health professional suggests something else.
The health field keeps moving. Safer options exist. Paracetamol offers relief without hurting the stomach. Doctors often turn to ibuprofen for pain or fever in older children and adults. Both medicines also make it easier for families to avoid nasty surprises. If someone experiences unusual symptoms after taking any medicine, contacting a specialist makes sense. Lessons from real life say: stay cautious and respect the medicine cabinet.
Anyone caring for children with a fever or pain wants a treatment that’s both safe and effective. Benorilate combines two well-known medicines: paracetamol and aspirin. Doctors often recommend it for children when they want to treat fever or mild-to-moderate pain issues—think headaches, toothaches, or discomfort from colds. The thing to remember is that children aren’t just small adults; their bodies handle medicine differently, so you can’t just guess a dose or copy what works for an adult.
Parents and caregivers often feel nervous about getting the dose right. With Benorilate, always stick with the amount the pharmacist or doctor suggests. The measuring spoon or dosing syringe that comes with the bottle isn’t just a nice extra; that’s how you avoid mistakes. An extra spoonful to help a fussy kid sleep or skipping a dose if symptoms seem mild—these choices can mean trouble. One safe practice is marking down the time you gave each dose in a notebook or your phone. That way, nobody doubles up or misses a dose when life gets busy.
Young children often refuse medicine—especially if it tastes strange or upsets their stomach. Benorilate usually goes down easier after a meal. This small step makes it less likely for a child to experience any stomach upset, and most caregivers find it turns an argument into a routine. Drinking a full glass of water after taking Benorilate can also make things easier for the stomach.
No parent wants to see a child feeling worse after treatment. Side effects such as nausea, skin rashes, or unusual bleeding might signal a problem. Parents who notice these changes need to call the doctor right away, not push through or hope things improve. Children who already have allergies to aspirin—or face issues such as asthma—often face greater risks from combination medicines. People with asthma sometimes react poorly to aspirin-like medicines, and a quick conversation with the family doctor usually clears up whether Benorilate is a safe option at all.
Getting instructions directly from your doctor or pharmacist eliminates a lot of confusion. One parent may hear “every six hours” and stretch it further, hoping to use less medicine. Another may double up, expecting a faster recovery. Writing down the advice and reading medicine leaflets before that first spoonful leads to safer outcomes. Parents should always update their doctor if a child takes any other prescription or over-the-counter remedy; certain antibiotics and cough suppressants don’t mix safely with Benorilate.
Carelessness with medicine storage happens—bottle on the nightstand, cap left loose, child-proof lids forgotten. A child who takes multiple doses in a day might suffer serious health problems. High up and locked away is never just a guideline. Expired Benorilate or leftover medicine belongs back at the pharmacy. Flushing it or tossing it out with regular trash creates environmental hazards.
Medicine makers spend years refining how medicine tastes, how easy it is to give, and how safely it works. Children’s health relies on the adults around them staying focused on clear dosing, good communication with medical staff, and careful oversight at home. That effort, plain and simple, forms the backbone of smart, safe medicine use at every age.
Benorilate used to make its way onto pharmacy shelves as a pain and fever medication for kids. Doctors and parents hoped it could calm fevers and ease aches. What gets less attention is how the compound actually works. Benorilate breaks down in the body to release both aspirin and paracetamol. This dual action led some folks to see it as handy – two drugs in one tablet. On the surface, this idea sounds efficient, but real-life use brings up some red flags.
I remember a debate in pediatric circles about “aspirin combinations” after a few children landed in the hospital with unexpected side effects. The core concern? Aspirin and children mix like oil and water, especially under the age of 12. Strong links connect aspirin with Reye’s syndrome, a rare but dangerous condition that can follow viral illnesses like flu or chickenpox. Reye’s syndrome may sound unfamiliar, but it means swelling in the liver and brain – and it’s frightening to see a healthy child turn gravely ill after what seemed like a mild virus.
Several medical organizations—both in Europe and North America—warn doctors not to give aspirin to kids. Since Benorilate’s breakdown products include aspirin, it falls into the same category. The risk may be low, but when it comes to a child’s health, “low” is not good enough.
Modern pharmacies stock plenty of alternatives that do not carry the same kinds of risk. Paracetamol (acetaminophen) remains a sturdy choice for pain and fever. Ibuprofen also gets green lights for short-term use in children over six months. Both drugs went through extensive testing. Parents see clear guidelines on proper dosing, side effects, and age limits. Most doctors rarely see complications when these instructions get followed.
Countries like the UK and Canada have removed Benorilate from pharmacy shelves years ago. Others continue to review its place, but the trend speaks for itself. Medical experts and watchdog groups steer caregivers away from any “aspirin-containing” medicines, even those hiding inside combination tablets. Transparency about drug components gives parents the power to make informed choices.
Parents juggling sick kids need clear instructions, not confusion. Labels on medicine bottles should read plain and simple. Ingredient lists must mention aspirin with no fine print. Pharmacists play a big role in guiding families to the safest options. If a parent ever feels uncertain, double-checking with a health care provider saves worry down the line. Policy makers who decide what stays on the shelves have a responsibility to keep high-risk drugs out of the hands of the public when safer choices exist.
Mistakes in medicine do happen, but parents and health professionals learn fast. Each case of Reye’s syndrome linked to an aspirin-containing medicine swings the pendulum further away from drugs like Benorilate. Today, even if a parent stumbles across this drug at a pharmacy in another country, it pays to leave it on the shelf and ask for an alternative. While trends change and drugs evolve, putting children’s safety at the front of every decision never goes out of fashion.
Anyone dealing with chronic pain, fever, or rheumatoid arthritis probably recognizes the frustration of juggling several medications. Benorilate shows up on pharmacy shelves as a combination of aspirin and paracetamol (acetaminophen). Some people reach for Benorilate, expecting both pain relief and a break from inflammation. Most don’t give a second thought to what happens once it gets mixed with other commonly prescribed drugs.
Plenty of people assume over-the-counter painkillers can be stacked together without trouble. After all, both aspirin and paracetamol show up everywhere, from kitchen cabinets to first aid kits. Doctors often remind patients about possible risks, but the message doesn’t always stick. Start combining Benorilate with other anti-inflammatories like ibuprofen or naproxen, and stomach trouble, bleeding, and even kidney problems can sneak up faster than anyone expects.
I’ve seen people at clinics taking separate pills for headaches, another for joint pain, and something else after an injury. The risk goes up every time someone doubles down on NSAIDs – especially if they never check with a pharmacist about drug combinations. Most probably don’t realize that stacking NSAIDs or swallowing them alongside blood thinners (like warfarin) can cause dangerous bleeding. Even seemingly harmless combinations, like Benorilate and regular paracetamol, easily add up to a dangerous overdose that silently harms the liver.
Many older adults or those with health challenges face another concern. Heart disease, high blood pressure, and kidney disease turn drug mixing into risky business. Aspirin—even as part of Benorilate—can thin the blood, tip the balance on blood pressure meds, and hurt the kidneys over time. People taking diabetes drugs or gout medications find aspirin interfering with the way those treatments work, leaving symptoms less controlled or side effects harder to manage.
From my own experience working in community health, I’ve spoken with more than a few patients who showed up in the clinic with unexplained bruising or bleeding. Careful review of their medication list often brought the pattern to light. Mixing painkillers was the hidden culprit, especially as patients tried to manage chronic pain and didn’t disclose everything during a rushed appointment.
The best way to protect yourself starts with honest conversation. Bring a written list of medications, supplements, and over-the-counter options to every doctor visit. Ask how each medication might interact. FDA guidance notes that mixing aspirin or paracetamol with other drugs changes how each one behaves in the body, often in unpredictable ways. Pharmacies and electronic health records can catch dangerous interactions but only if the records are complete and accurate.
For those dealing with ongoing pain, the idea of rotating painkillers instead of stacking them may help. Sticking to one well-tolerated medication with medical supervision usually beats risky combinations. If something isn’t working, don’t reach for another without checking in with a healthcare professional first.
Clear, honest conversation between doctors, pharmacists, and patients stops many problems before they start. Family caregivers can play a huge role by double-checking medicine cabinets and creating up-to-date medication lists. Health professionals should avoid “just-in-case” recommendations and push for clarity when writing prescriptions.
Stories from hospitals and clinics show medication errors can happen to anyone. The solution comes from building trust, bit by bit, across every link in the healthcare chain. No one expects to get hurt when trying to feel better, but too many medications mixed together makes that risk all too real.
| Names | |
| Preferred IUPAC name | 4-acetoxybenzoic acid 2-(acetyloxy)phenyl ester |
| Other names |
Benorylate acetylsalicoyl-4-hydroxyacetanilide |
| Pronunciation | /bəˈnɔːrɪˌleɪt/ |
| Identifiers | |
| CAS Number | 5003-48-5 |
| Beilstein Reference | 4207007 |
| ChEBI | CHEBI:3036 |
| ChEMBL | CHEMBL1082 |
| ChemSpider | 2082 |
| DrugBank | DB01799 |
| ECHA InfoCard | ECHA InfoCard: 100.022.319 |
| EC Number | 259-551-3 |
| Gmelin Reference | 1465536 |
| KEGG | D07444 |
| MeSH | D001568 |
| PubChem CID | 2380 |
| RTECS number | DE3430000 |
| UNII | 0K47G2QG2H |
| UN number | UN3166 |
| Properties | |
| Chemical formula | C17H19NO5 |
| Molar mass | 321.348 g/mol |
| Appearance | White crystalline powder |
| Odor | Odorless |
| Density | 1.24 g/cm³ |
| Solubility in water | Practically insoluble |
| log P | 1.66 |
| Vapor pressure | 8.0E-10 mmHg |
| Acidity (pKa) | 13.46 |
| Basicity (pKb) | 13.54 |
| Magnetic susceptibility (χ) | -7.3e-6 |
| Refractive index (nD) | 1.580 |
| Viscosity | Viscous liquid |
| Dipole moment | 6.16 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 510.6 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -577.1 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | -11240.8 kJ/mol |
| Pharmacology | |
| ATC code | N02BA15 |
| Hazards | |
| Main hazards | Harmful if swallowed. May cause respiratory irritation. |
| GHS labelling | GHS labelling of Benorilate: **"Warning; H302, H319, P264, P270, P305+P351+P338, P337+P313"** |
| Pictograms | 👄💊🧸 |
| Signal word | Warning |
| Hazard statements | H302 + H315 + H319 |
| Precautionary statements | Keep out of reach of children. If swallowed, seek medical advice immediately and show this container or label. Avoid contact with eyes and skin. Wear suitable protective clothing and gloves. |
| NFPA 704 (fire diamond) | 1-2-0 |
| Flash point | 113°C |
| Autoignition temperature | 300°C |
| Lethal dose or concentration | LD50 rat oral 2,300 mg/kg |
| LD50 (median dose) | LD50 2100 mg/kg (oral, rat) |
| NIOSH | RN:5003-48-5 |
| PEL (Permissible) | Not established |
| REL (Recommended) | 20 to 40 mg/kg daily |
| IDLH (Immediate danger) | Not Listed |
| Related compounds | |
| Related compounds |
Aspirin Paracetamol |
